医学
贝伐单抗
埃罗替尼
胆囊
打开标签
随机对照试验
内科学
胆囊癌
肿瘤科
化疗
癌症
表皮生长因子受体
作者
Anant Ramaswamy,Prabhat Bhargava,S. Srinivas,Akhil Kapoor,Bal Krishna Mishra,Anuj Gupta,Sarika Mandavkar,Sadhana Kannan,Deepali Chaugule,Rajshree Patil,Manali Parulekar,Chaitali Nashikkar,Suman Kumar Ankathi,Rajiv Kumar,Deepali Naughane,Anuprita Daddi,Neha Jagdish Mer,Nitin Shetty,Vikas Ostwal
摘要
Patients with chemotherapy-responsive advanced biliary tract cancers (BTCs) are usually observed after 6 months of gemcitabine-based therapy. There is limited prospective evidence for maintenance strategies after chemotherapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI